<DOC>
	<DOC>NCT00676117</DOC>
	<brief_summary>The purpose of this study is to evaluate the pharmacokinetic profile of Esomeprazole (D961H) during repeated oral administration with and without co-administration of loxoprofen and the pharmacokinetic profile of loxoprofen during repeated oral administration with and without co-administration of Esomeprazole (D961H).</brief_summary>
	<brief_title>Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males</brief_title>
	<detailed_description />
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy Japanese male Body Mass Index (BMI=weight/height2) 1927 (kg/m2) Body weight 5080 kg Past or present NSAIDs induced asthma, hepatic dysfunction, peptic ulcer or blood disorders Significant clinical illness from the 2 weeks preceding the preentry visit to the randomisation, as judged by the investigator(s) , eg, acute inflammatory disease which requires medical intervention Past or present cardiac, renal, hepatic, neurological or gastrointestinal disease, as judged by the investigator(s), eg, sequelae of myocardial infarction, nephritis, hepatitis and cerebral infarction</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>male</keyword>
	<keyword>Japan</keyword>
	<keyword>Japanese</keyword>
	<keyword>Healthy volunteers</keyword>
</DOC>